The annual rate of decline in the FVC in patients with progressive fibrosing Interstitial Lung Diseases was significantly lower among patients who received Nintedanib than placebo.
Journal Club - Nintedanib in Progressive Fibrosing ILDs
Journal Club - Stability of Blood EOS as COPD phenotype prediction
The use of blood eosinophil levels as a biomarker of exacerbation risk and responsiveness of COPD patients to inhaled corticosteroids (ICS).
Journal Club - Prevalence of AFib with End-Stage COPD
Evaluation of the prevalence of Atrial Fibrillation in Hospital Encounters with End-Stage COPD on Home Oxygen.
Journal Club - Mometasone or Tiotropium in Mild Asthma (low sEOS)
Mometasone or Tiotropium in Mild Asthma with a Low Sputum Eosinophil Level. 73% had low sputum eosinophil level and 59% had a response to either drug vs placebo.
Journal Club - Tripple Therapy vs Dual therapy
Benefits of triple therapy for chronic symptomatic COPD with ICS, LAMA and LABA vs dual therapy with ICS + LABA or LAMA + LABA.
CAT test in Patients with Connective Tissue Disease-assoc. ILD
CAT (COPD Assessment Test) by examining its reliability, validity and responsiveness in patients with CTD-ILD.
Journal Club - Role of CT Honeycombing in ILD progression
This study was focused on determining the prevalence and prognostic value of CT honeycombing and characterize associated mortality patterns across diverse ILD subtypes in a multicenter cohort.
Journal Club - ICS potency and therapeutic index
This study focused on the comparison of pharmacological parameters and safety characteristics of different ICS used in treatment of asthma and COPD.
Journal Club - Effectiveness of Breo Elipta on Asthma
Effectiveness of fluticasone furoate plus vilanterol on asthma control in clinical practice: an open-label, parallel group, randomized controlled trial.
Journal Club - Overdiagnosis of COPD with Unobstructed Spirometry
CHEST 2019 report: overdiagnosis of COPD and the prevalence of spirometrically defined false positive COPD.
- 1 of 4
- next ›